High-affinity cytochalasin B binding to normal and transformed BALB/3T3 cells

Researchers have long examined how physiological states influence cellular processes like sugar uptake. Prior studies have established that changes in cell growth and transformation can affect transport mechanisms. However, the exact molecular basis of these changes remains unclear. While some research has linked cell surface receptors to transport activity, the role of cytochalasin B binding in this context is less understood. No prior work had resolved how binding dynamics differ between normal and transformed cells. This gap motivated the current investigation into cytochalasin B interactions. The study aimed to clarify whether binding site numbers correlate with physiological state. By comparing binding in various cell lines, the research sought to identify patterns in drug-cell interactions. These findings could inform broader studies on transport regulation in different cell types.

The goal was to investigate how cytochalasin B binding varies across different physiological states of cultured mouse fibroblasts. Researchers focused on comparing normal and transformed cell lines to understand transport regulation. They measured binding in actively growing and contact-inhibited cells, as well as in 3T12 and SV3T3 cells. The study aimed to determine if binding site numbers differ between these states. By analyzing binding under various conditions, the team sought to identify consistent patterns. They also wanted to assess whether binding is affected by external factors like glucose. The research aimed to clarify if binding site density correlates with cell type or growth state. This work could shed light on the molecular basis of sugar uptake differences.

The team used [3H] cytochalasin B to measure high-affinity binding in different cell lines. They tested both intact and sonicated cells using centrifugation and dialysis assays. The study compared binding in actively growing and contact-inhibited Balb/3T3 cells. They also analyzed 3T12 and SV3T3 cells to assess differences in binding capacity. The researchers examined whether detachment methods affected binding results. They used EDTA and trypsin to detach cells and found no significant differences. Binding kinetics were assessed over a range of drug concentrations. The team evaluated reversibility and the impact of 0.1 M D-glucose on binding.

Cytochalasin B binding was rapid and reversible across all tested cell lines. The amount of drug bound to intact cells matched that in sonicates, indicating consistent binding. Binding was unaffected by 0.1 M D-glucose in the assay medium. Actively growing and contact-inhibited 3T3 cells showed similar binding site numbers. In contrast, 3T12 and SV3T3 cells had one third to one fourth the number of sites. The number of sites per microgram of cellular protein was similar across all conditions. These results suggest that binding site density is not directly linked to cell type. The findings indicate that physiological state does not significantly alter binding site numbers.

The study found that cytochalasin B binding site numbers are consistent across different physiological states. Actively growing and contact-inhibited 3T3 cells had similar site counts. Transformed 3T12 and SV3T3 cells had fewer sites but similar site density per protein. The researchers suggest that binding site density is not a key factor in transport differences. They propose that other mechanisms may regulate sugar uptake in these cells. The results indicate that binding is not affected by glucose in the assay medium. The team concludes that detachment methods do not influence binding measurements. These findings support the idea that physiological state does not directly alter binding site numbers.